Observational study / 2009
Coffee intake was linked to higher hypertension risk in slow CYP1A2 metabolizers, but lower risk in rapid metabolizers.
Researchers prospectively followed 553 young White individuals screened for stage 1 hypertension over a median of 8.2 years, during which 323 developed hypertension. Among carriers of the slow CYP1A2 *1F allele, multivariable hazard ratios for hypertension were 1.72 (95% CI, 1.21-2.44; P = 0.03) for moderate coffee drinkers and 3.00 (1.53-5.90; P = 0.001) for heavy drinkers compared to abstainers. For rapid *1A/*1A genotypes, hazard ratios were 0.80 (0.52-1.23; P = 0.29) for moderate and 0.36 (0.14-0.89; P = 0.026) for heavy drinkers. A significant gene x coffee interaction was found for follow-up changes in systolic (P = 0.000) and diastolic (P = 0.007) blood pressure.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 553 young White individuals screened for stage 1 hypertension
- What was measured
- Incident physician-diagnosed hypertension
THE PAPER
CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension.
Palatini P, Ceolotto G, Ragazzo F, Dorigatti F, Saladini F, Papparella I, Mos L, Zanata G, Santonastaso M. J Hypertens, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.